Lataa...

CYP46A1-dependent and independent effects of efavirenz treatment

Cholesterol excess in the brain is mainly disposed via cholesterol 24-hydroxylation catalysed by cytochrome P450 46A1, a CNS-specific enzyme. Cytochrome P450 46A1 is emerging as a promising therapeutic target for various brain diseases with both enzyme activation and inhibition having therapeutic po...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Brain Commun
Päätekijät: Mast, Natalia, El-Darzi, Nicole, Petrov, Alexey M, Li, Young, Pikuleva, Irina A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7713991/
https://ncbi.nlm.nih.gov/pubmed/33305262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcaa180
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!